Solid Biosciences Inc. — Director's Dealing 2026

Jan 7, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2026-01-03

Reporting Person: Ganot Ilan (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-03	Common Stock	M	2994	—	Acquired	18331	Indirect
2026-01-05	Common Stock	S	1053	$5.43	Disposed	17278	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-03	Restricted Stock Units	$	M	2994	Disposed		Common Stock (2994)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	95413	Direct
Common Stock	19394	Indirect

Footnotes

F1: Restricted stock units convert to common stock on a one-for-one basis.

F2: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.

F3: Represents 91,371 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F4: Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F5: On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.